HAIR Restoration Robotics Inc

Restoration Robotics™ Unveils ARTAS® iX, the Most Advanced Robotic Hair Restoration System, At The Aesthetic Show™ 2018

Restoration Robotics™ Unveils ARTAS® iX, the Most Advanced Robotic Hair Restoration System, At The Aesthetic Show™ 2018

Presentations by CEO and COO draw attention and enthusiasm by attendees

Launch marks pivotal moment in hair restoration

SAN JOSE, Calif., July 07, 2018 (GLOBE NEWSWIRE) --  Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, today provided an update from The Aesthetic Show™ 2018 where the Company unveiled its new ARTAS® iX Robotic Hair Restoration System during a mainstage presentation and a pre-show educational session to attendees. The ARTAS iX Robotic Hair Restoration System is the first and only robotic intelligent solution to offer precise, minimally invasive, repeatable harvesting and implantation functionality in one platform.

Ryan Rhodes, Chief Executive Officer of Restoration Robotics, unveiled the new ARTAS iX System and the opportunity it presents to aesthetic physicians during a presentation to a full room of attendees on Friday, July 6th on the Main Stage in the Exhibit Hall.

Gabe Zingaretti, Dott. Ing., Chief Operations Officer of Restoration Robotics, presented an overview of the ARTAS iX System and its new capabilities to attendees on Thursday, July 5th in a Pre-Show Educational Session titled “The Art of Male Aesthetics Symposium.”

Ryan Rhodes commented, “Worldwide, approximately 1.2 billion men suffer from hereditary baldnessi , ii and there is a growing demand for less invasive hair restoration proceduresiii. We have the most advanced robotic technology and now are taking hair restoration to a higher level with the robotic implantation fuctionality. We believe the introduction of the ARTAS iX System is a pivotal moment for Restoration Robotics and the positive reaction and enthusiasm expressed by attendees at The Aesthetic Show is certainly encouraging.”

Dr. Zingaretti added, “Restoration Robotics has been pioneering robotic hair restoration for more than a decade. The ARTAS iX System is the culmination of over three years of research, engineering and clinical  development based on input from leading hair restoration surgeons and our valued customers. We responded with the ARTAS iX System: a complete solution that integrates graft harvesting, simultaneous recipient site-making and implantation.” 

The Aesthetic Show™ 2018 is being held July 5-8 at The Wynn Hotel in Las Vegas, NV. For more information on the ARTAS iX Robotic Hair Restoration System visit .

About Restoration Robotics

Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS™ Robotic Hair Restoration System. The ARTAS System is the first and only physician-assisted system to dissect and assist in the harvesting of follicular units directly from the scalp, create recipient implant sites using proprietary algorithms and now implant the hair follicles into the designated sites. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.

Forward-looking Statements



Statements made in this press release that are not statements of historical fact are forward-looking statements. Forward-looking statements are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are commonly identified by words such as “would,” “may,” “expects,” “believes,” “plans,” “intends,” “projects” and other terms with similar meaning. Investors are cautioned that the forward-looking statements in this press release are based on current beliefs, assumptions and expectations, speak only as of the date of this document and involve risks and uncertainties that could cause actual results to differ materially from current expectations. Such statements are subject to certain known and unknown risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results and other future events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.  These statements include, without limitation, the following: our expectations for the global male hair restoration market; our expectations regarding the ability of ARTAS iX to deliver outstanding results and reduce clinical fatigue; whether there is growth in demand for our ARTAS System; the progress of our commercialization, marketing and manufacturing capabilities; the continuing productivity and effectiveness of our commercial infrastructure and salesforce; our expectations regarding the potential market size and the size of the patient populations for ARTAS being accurate; and whether we are effective in the pricing of ARTAS iX. Material factors that could cause actual results to differ materially from current expectations are described in greater detail in our Annual Report on Form 10-K filed on March 5, 2018, as well as any reports that we may file with the SEC in the future. These factors may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. We expressly disclaim any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

Media Contact

Lisa Markle

Director of Marketing

Restoration Robotics, Inc.



Investor Contact

The Ruth Group

Lee Roth & Brian Johnston



646-536-7000

i

ii

iii *ISHRS 2017 Practice Census Results

EN
07/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Restoration Robotics Inc

 PRESS RELEASE

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial ...

Venus Concept Announces Fourth Quarter and Fiscal Year 2019 Financial Results; Provides Preliminary First Quarter of 2020 Revenue Results and Updates Fiscal Year 2020 Revenue Guidance TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months and twelve months ended December 31, 2019 and preliminary revenue results for the three months ending March 31, 2020. The Company notes that the financial results provided for the three months and twelv...

 PRESS RELEASE

Venus Concept Inc. Announces $22.25 Million Equity Financing

Venus Concept Inc. Announces $22.25 Million Equity Financing TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entered into a definitive agreement for the sale of shares of its common stock, Series A convertible preferred stock and warrants to purchase common stock in a private placement to a group of investors, including EW Healthcare Partners, HealthQuest Capital and SEDCO Capital. The private placement is expected to result in gross proceeds to the Compa...

 PRESS RELEASE

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial...

Venus Concept to Release Fourth Quarter and Fiscal Year 2019 Financial Results on March 30, 2020 TORONTO, March 10, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2019 financial results will be released after the market closes on Monday, March 30. Management will host a conference call at 5:00 p.m. Eastern Time on March 30 to discuss the results of the quarter and the year with a question and answer session. Those who would like to participate may di...

 PRESS RELEASE

Venus Concept Expands Executive Team

Venus Concept Expands Executive Team Chad A. Zaring, Appointed Chief Commercial Officer TORONTO, March 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that it has expanded its Executive Team with the appointment of Chad A. Zaring to the newly-created role of Chief Commercial Officer (“CCO”), effective February 10, 2020. Mr. Zaring has extensive experience in building and executing commercial strategies and driving sales for leading surgical robotics companies in his career. “We ar...

 PRESS RELEASE

Venus Concept Inc. Announces New Regulatory Clearances

Venus Concept Inc. Announces New Regulatory Clearances CE Mark Approval for Venus Bliss™️ for Non-Invasive Lipolysis of Abdomen & Flanks, Skin Tightening, Circumferential Reduction and Cellulite ReductionHealth Canada License to Market NeoGraft 2.0 for hair restoration TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks, skin tightening, circumferential re...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch